We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In 2021, Humira — the blockbuster ...
Cigna Group-owned Evernorth Health Services said Thursday it would provide a Humira biosimilar with no out-of-pocket fees starting in June. The pharmacy and benefits provider said the biosimilar for ...
The company won't launch its lookalike version of AbbVie's Humira until July, though it was approved by the FDA in December 2021. A 20-year-old biologic drug targeting multiple diseases — from ...
CVS Caremark, the pharmaceutical subsidiary of CVS Health, announced Wednesday it will replace AbbVie’s Humira from its list of covered drugs with cheaper alternatives for some customers—a move that’s ...
This year, there has been an influx of biosimilars aiming to capture a share of the $20 billion annual revenue generated by AbbVie's mega biologic blockbuster Humira. However, these copycat biologics ...
After 20 years and $200 billion in revenue, Humira — an injectable treatment for rheumatoid arthritis and several other autoimmune conditions — has lost its monopoly. Early Tuesday morning, California ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback